Cystoid Macular Oedema (CME) and Immune Responses after DMEK/Triple DMEK: Real Life Data from Oregis.

IF 0.7 4区医学 Q4 OPHTHALMOLOGY

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-09-25 DOI:10.1055/a-2650-9712

Johanna Wiedemann, Christopher Dicke, Björn O Bachmann, Lebriz Altay, Claus Cursiefen

{"title":"Cystoid Macular Oedema (CME) and Immune Responses after DMEK/Triple DMEK: Real Life Data from Oregis.","authors":"Johanna Wiedemann, Christopher Dicke, Björn O Bachmann, Lebriz Altay, Claus Cursiefen","doi":"10.1055/a-2650-9712","DOIUrl":null,"url":null,"abstract":"Background: Oregis is the multi-centre registry of the German Ophthalmological Society, that systematically collects a comprehensive data set on ophthalmological care in Germany. Here we present the first analysis of Descemet Membrane Endothelial Keratoplastic (DMEK). Only two of the following centres provided the data presented here, but, in the future, participation in Oregis will increase so that data from different eye hospitals and clinics and outpatient and inpatient treatments will be covered.Objectives: Overview of real-life care after DMEK in Germany.Methods: The data was analysed using SweetVIZ 2.1.4. SweetViz is an open-source Python library for automated exploratory data analysis (EDA). Statistical tests were performed using R.Results: Cystoid macular oedema (CME) and immune response are significant complications of DMEK, and both are treated by corticosteroids.Discussion: The future expansion of the register will provide data on the current situation and indicate possible improvements in postoperative care in Germany.","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinische Monatsblatter fur Augenheilkunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2650-9712","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Oregis is the multi-centre registry of the German Ophthalmological Society, that systematically collects a comprehensive data set on ophthalmological care in Germany. Here we present the first analysis of Descemet Membrane Endothelial Keratoplastic (DMEK). Only two of the following centres provided the data presented here, but, in the future, participation in Oregis will increase so that data from different eye hospitals and clinics and outpatient and inpatient treatments will be covered.

Objectives: Overview of real-life care after DMEK in Germany.

Methods: The data was analysed using SweetVIZ 2.1.4. SweetViz is an open-source Python library for automated exploratory data analysis (EDA). Statistical tests were performed using R.

Results: Cystoid macular oedema (CME) and immune response are significant complications of DMEK, and both are treated by corticosteroids.

Discussion: The future expansion of the register will provide data on the current situation and indicate possible improvements in postoperative care in Germany.

查看原文本刊更多论文

[膀胱样黄斑水肿（CME）和DMEK/三重DMEK后的免疫反应：来自俄勒冈州的真实数据]。

背景：Oregis是德国眼科学会的多中心注册，系统地收集了德国眼科护理的综合数据集。在这里，我们提出了第一个分析Descemet膜内皮角膜形成（DMEK）。只有以下两个中心提供了本文所述的数据，但今后将增加对Oregis的参与，以便涵盖来自不同眼科医院和诊所以及门诊和住院治疗的数据。目的：概述德国DMEK术后的现实护理。方法：采用SweetVIZ 2.1.4软件对数据进行分析。SweetViz是一个用于自动探索性数据分析（EDA）的开源Python库。结果：囊样黄斑水肿（CME）和免疫反应是DMEK的显著并发症，两者均可通过皮质类固醇治疗。讨论：未来登记册的扩大将提供当前情况的数据，并指出德国术后护理可能的改进。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Klinische Monatsblatter fur Augenheilkunde 医学-眼科学

CiteScore

1.30

自引率

0.00%

发文量

235

审稿时长

4-8 weeks

期刊介绍： -Konzentriertes Fachwissen aus Klinik und Praxis: Die entscheidenden Ergebnisse der internationalen Forschung - für Sie auf den Punkt gebracht und kritisch kommentiert, Übersichtsarbeiten zu den maßgeblichen Themen der täglichen Praxis, Top informiert - breite klinische Berichterstattung. -CME-Punkte sammeln mit dem Refresher: Effiziente, CME-zertifizierte Fortbildung, mit dem Refresher, 3 CME-Punkte pro Ausgabe - bis zu 36 CME-Punkte im Jahr!. -Aktuelle Rubriken mit echtem Nutzwert: Kurzreferate zu den wichtigsten Artikeln internationaler Zeitschriften, Schwerpunktthema in jedem Heft: Ausführliche Übersichtsarbeiten zu den wichtigsten Themen der Ophthalmologie – so behalten Sie das gesamte Fach im Blick!, Originalien mit den neuesten Entwicklungen, Übersichten zu den relevanten Themen.